Skip to content

A study for the effect of COVID-19 on childhood asthma

A study for the effect of COVID-19 on childhood asthma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0009040
Enrollment
500
Registered
2023-12-14
Start date
2023-11-27
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Among the pediatric asthma patients built in 2016-2018 who can be tracked 2. 11–23 years of age who have asthma symptoms (whirring, dyspnea, or chronic/repetitive cough) in the last 12 months and satisfy bronchodilator response = 12% (based on baseline FEV1 levels) or PC20 methacholine = 16 mg/mL or PD15 mannitol = 635 mg

Exclusion criteria

Exclusion criteria: 1. Among the patients currently visiting the Department of Pediatrics at Asan Medical Center in Seoul, subjects aged 11-23 without childhood asthma or allergic diseases

Design outcomes

Primary

MeasureTime frame
bronchial potential for asthma

Secondary

MeasureTime frame
pulmonary function

Countries

Korea, Republic of

Contacts

Public ContactJinho Yu

University of Ulsan

jyu3922@gmail.com+82-2-3010-392

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026